据最新研究显示,患慢性阻塞性肺疾病(COPD)的老年人使用新阿片类药物处方,面临的呼吸方面的负面风险将增加,包括死亡风险。使用新阿片类药物的COPD患者可能性死亡率是未使用阿片类药物患者的4倍,发现对于未接受姑息治疗的COPD患者,阿片类药物处方的使用率很高。对于COPD患者,阿片类药物可以引起呼吸道抑制,减少黏液间隙及免疫抑制。研究人员称,在对于COPD患者使用处方阿片类药物的研究调查显示有利有弊,可能会增加死亡率。为弄清楚阿片类药物在COPD患者中 According to the latest research, the prescription of new opioids in elderly people with chronic obstructive pulmonary disease (COPD) exposes them to increased negative respiratory risks, including the risk of death. COPD patients using new opioids have a four-fold lower likelihood of mortality than those without opiates and found that the use of opiates was high for COPD patients who did not receive palliative care. For COPD patients, opioids can cause respiratory depression, reduce mucus clearance and immunosuppression. Investigators say pros and cons of investigating opioid use in patients with COPD may increase mortality. To clarify opioids in COPD patients